BARRIER REVERSE CONVERTIBLE - AMGEN | Market Closed - Swiss Exchange 11:15:00 2024-03-08 am EST | ||
| 100.4 USD | +0.10% |
|
| 6 months | +0.10% | ||
| Current year | +0.10% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
Static data
| Product type | Reverse Convertibles |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| RAMANV | |
| ISIN | CH1275367311 |
| Date issued | 2023-06-22 |
| Strike | 228.3 $ |
| Maturity | 2024-06-21 (35 Days) |
| Parity | 0.23 : 1 |
| Emission price | 100 $ |
| Emission volume | N/A |
| Settlement | both |
| Currency | USD |
Technical Indicators
| Highest since issue | 100.6 $ |
|---|---|
| Lowest since issue | 99.8 $ |
| Spread | 5 $ |
| Spread % | 0.50% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Certificates
- RAMANV Certificat
